Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| ALKT | Shootman Alex | Chief Executive Officer | 08.09.2026 | Steuer-Abgabe | 19,38 | 16.188 | 313.723 | Form 4 |
| ALKS | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 03.09.2026 | Verkauf | 48,01 | 2.034 | 97.652 | Form 4 |
| ALKT | Sachdeva Prerna | Chief Accounting Officer | 01.09.2026 | Steuer-Abgabe | 19,44 | 1.421 | 27.624 | Form 4 |
| ALKT | Linebarger Douglas A. | Chief Legal Officer | 01.09.2026 | Steuer-Abgabe | 19,44 | 7.381 | 143.487 | Form 4 |
| ALKT | Hudson Cassandra | Chief Financial Officer | 01.09.2026 | Steuer-Abgabe | 19,44 | 8.293 | 161.216 | Form 4 |
| ALKT | Shootman Alex | Chief Executive Officer | 01.09.2026 | Steuer-Abgabe | 19,44 | 5.205 | 101.185 | Form 4 |
| ALKS | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 01.09.2026 | Verkauf | 46,99 | 9.000 | 422.874 | Form 4 |
| ALKS | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 01.09.2026 | Optionsausübung | 24,59 | 5.000 | 122.950 | Form 4 |
| ALK | Minicucci Benito | CEO AND PRESIDENT | 20.08.2026 | Kauf | 40,06 | 25.000 | 1.001.510 | Form 4 |
| ALKS | Nichols Christian Todd | SVP, Chief Commercial Officer | 17.08.2026 | Verkauf | 49,65 | 664 | 32.969 | Form 4 |
| ALKS | Nichols Christian Todd | SVP, Chief Commercial Officer | 17.08.2026 | Verkauf | 49,19 | 6.912 | 339.967 | Form 4 |
| ALKT | Hudson Cassandra | Chief Financial Officer | 07.08.2026 | Zuteilung | — | 52.116 | — | Form 4 |
| ALK | Harrison Andrew R | EVP AND CCO | 03.08.2026 | Verkauf | 49,67 | 5.300 | 263.256 | Form 4 |
| ALKS | snyderman nancy lynn MD | Director | 03.08.2026 | Verkauf | 50,35 | 44.472 | 2.239.076 | Form 4 |
| ALKS | snyderman nancy lynn MD | Director | 03.08.2026 | Optionsausübung | 46,72 | 16.524 | 772.001 | Form 4 |
| ALKS | snyderman nancy lynn MD | Director | 03.08.2026 | Optionsausübung | 46,72 | 27.948 | 1.305.731 | Form 4 |
| ALKS | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 03.08.2026 | Verkauf | 48,58 | 9.000 | 437.220 | Form 4 |
| ALKS | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 03.08.2026 | Optionsausübung | 24,59 | 4.896 | 120.393 | Form 4 |
| ALKS | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 03.08.2026 | Optionsausübung | 19,34 | 104 | 2.011 | Form 4 |
| ALKS | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 03.08.2026 | Verkauf | 48,58 | 2.034 | 98.812 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).